Lipid mediator serum profiles in asthmatics significantly shift following dietary supplementation with omega-3 fatty acids

Molecular Nutrition and Food Research

Volumn 57, Issue 8, 2013, Pages 1378-1389

  Lundström, Susanna L ^a   Yang, Jun ^b   Brannan, John D ^c,d   Haeggström, Jesper Z ^a   Hammock, Bruce D ^b   Nair, Parameswaran ^c   O'Byrne, Paul ^c   Dahlén, Sven Erik ^a   Wheelock, Craig E ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MCMASTER UNIVERSITY   (Canada)

^d WESTMEAD HOSPITAL   (Australia)

Author keywords

Asthma; Eicosanoid; Lipidomics; Omega 3; Oxylipin

Indexed keywords

DOCOSAHEXAENOIC ACID; ICOSANOID; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; OXYLIPIN; PHOSPHOLIPID;

ADULT; ARTICLE; ASTHMA; BLOOD; CHEMISTRY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIET THERAPY; FEMALE; HUMAN; LIPIDOMICS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OMEGA-3; RANDOMIZED CONTROLLED TRIAL; YOUNG ADULT;

ASTHMA; EICOSANOID; LIPIDOMICS; OMEGA-3; OXYLIPIN;

ADULT; ASTHMA; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OXYLIPINS; PHOSPHOLIPIDS; YOUNG ADULT;

EID: 84881276490     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201200827     Document Type: Article

References (56)

1. Baum, S. J., Kris-Etherton, P. M., Willett, W. C., Lichtenstein, A. H. et al., Fatty acids in cardiovascular health and disease: a comprehensive update. J. Clin. Lipidol. 2012, 6, 216-234.
2. De Caterina, R., n-3 fatty acids in cardiovascular disease. N. Engl. J. Med. 2011, 364, 2439-2450.
3. Saravanan, P., Davidson, N. C., Schmidt, E. B., Calder, P. C., Cardiovascular effects of marine omega-3 fatty acids. Lancet 2010, 376, 540-550.
4. Kris-Etherton, P. M., Harris, W. S., Appel, L. J., AHA Nutrition Committee. American Heart Association, Omega-3 fatty acids and cardiovascular disease: new recommendations from the American Heart Association. Arterioscler. Thromb. Vasc. Biol. 2003, 23, 151-152.
5. Kris-Etherton, P. M., Harris, W. S., Appel, L. J., American Heart Association. Nutrition Committee, Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002, 106, 2747-2757.
6. Dumlao, D. S., Cunningham, A. M., Wax, L. E., Norris, P. C. et al., Dietary fish oil substitution alters the eicosanoid profile in ankle joints of mice during lyme infection. J. Nutr. 2012, 142, 1582-1589.
7. Norris, P. C., Dennis, E. A., Omega-3 fatty acids cause dramatic changes in TLR4 and purinergic eicosanoid signaling. Proc. Natl. Acad. Sci. USA 2012, 109, 8517-8522.
8. Keenan, A. H., Pedersen, T. L., Fillaus, K., Larson, M. K. et al., Basal omega-3 fatty acid status affects fatty acid and oxylipin responses to high-dose n3-HUFA in healthy volunteers. J. Lipid Res. 2012, 53, 1662-1669.
9. Lundstrom, S. L., Balgoma, D., Wheelock, A. M., Haeggstrom, J. Z. et al., Lipid mediator profiling in pulmonary disease. Curr. Pharm. Biotechnol. 2011, 12, 1026-1052.
10. Samuelsson, B., Dahlen, S. E., Lindgren, J. A., Rouzer, C. A. et al., Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science 1987, 237, 1171-1176.
11. Funk, C. D., Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 2001, 294, 1871-1875.
12. Haeggstrom, J. Z., Funk, C. D., Lipoxygenase and leukotriene pathways: biochemistry, biology, and roles in disease. Chem. Rev. 2011, 111, 5866-5898.
13. Capra, V., Back, M., Barbieri, S. S., Camera, M. et al., Eicosanoids and their drugs in cardiovascular diseases: focus on atherosclerosis and stroke. Med. Res. Rev. 2013, 33, 364-438.
14. Tremoli, E., Folco, G., Agradi, E., Galli, C., Platelet thromboxanes and serum-cholesterol. Lancet 1979, 1, 107-108.
15. Capone, C., Faraco, G., Anrather, J., Zhou, P. et al., Cyclooxygenase 1-derived prostaglandin E2 and EP1 receptors are required for the cerebrovascular dysfunction induced by angiotensin II. Hypertension 2010, 55, 911-917.
16. Davi, G., Catalano, I., Averna, M., Notarbartolo, A. et al., Thromboxane biosynthesis and platelet function in type II diabetes mellitus. N. Engl. J. Med. 1990, 322, 1769-1774.
17. Davi, G., Guagnano, M. T., Ciabattoni, G., Basili, S. et al., Platelet activation in obese women: role of inflammation and oxidant stress. JAMA 2002, 288, 2008-2014.
18. Di Gennaro, A., Wagsater, D., Mayranpaa, M. I., Gabrielsen, A. et al., Increased expression of leukotriene C4 synthase and predominant formation of cysteinyl-leukotrienes in human abdominal aortic aneurysm. Proc. Natl. Acad. Sci. USA 2010, 107, 21093-21097.
19. Serhan, C. N., Chiang, N., Van Dyke, T. E., Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat. Rev. Immunol. 2008, 8, 349-361.
20. Kohli, P., Levy, B. D., Resolvins and protectins: mediating solutions to inflammation. Br. J. Pharmacol. 2009, 158, 960-971.
21. Wall, R., Ross, R. P., Fitzgerald, G. F., Stanton, C., Fatty acids from fish: the anti-inflammatory potential of long-chain omega-3 fatty acids. Nutr. Rev. 2010, 68, 280-289.
22. Shearer, G. C., Harris, W. S., Pedersen, T. L., Newman, J. W., Detection of omega-3 oxylipins in human plasma and response to treatment with omega-3 acid ethyl esters. J. Lipid Res. 2010, 51, 2074-2081.
23. Honstra, G., van Houwelingen, A. C., Kivits, G. A., Fischer, S. et al., Influence of dietary fish on eicosanoid metabolism in man. Prostaglandins 1990, 40, 311-329.
24. Arterburn, L. M., Hall, E. B., Oken, H., Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am. J. Clin. Nutr. 2006, 83, 1467S-1476S.
25. Conquer, J. A., Holub, B. J., Effect of supplementation with different doses of DHA on the levels of circulating DHA as non-esterified fatty acid in subjects of Asian Indian background. J. Lipid Res. 1998, 39, 286-292.
26. Marsen, T. A., Pollok, M., Oette, K., Baldamus, C. A., Pharmacokinetics of omega-3-fatty acids during ingestion of fish oil preparations. Prostaglandins Leukot. Essent. Fatty Acids 1992, 46, 191-196.
27. Zuijdgeest-van Leeuwen, S. D., Dagnelie, P. C., Rietveld, T., van den Berg, J. W. et al., Incorporation and washout of orally administered n-3 fatty acid ethyl esters in different plasma lipid fractions. Br. J. Nutr. 1999, 82, 481-488.
28. Roquet, A., Dahlen, B., Kumlin, M., Ihre, E. et al., Combined antagonism of leukotrienes and histamine produces predominant inhibition of allergen-induced early and late phase airway obstruction in asthmatics. Am. J. Respir. Crit. Care Med. 1997, 155, 1856-1863.
29. Yang, J., Schmelzer, K., Georgi, K., Hammock, B. D., Quantitative profiling method for oxylipin metabolome by liquid chromatography electrospray ionization tandem mass spectrometry. Anal. Chem. 2009, 81, 8085-8093.
30. Lundstrom, S. L., Levanen, B., Nording, M., Klepczynska-Nystrom, A. et al., Asthmatics exhibit altered oxylipin profiles compared to healthy individuals after subway air exposure. PLoS One 2011, 6, e23864.
31. Stark, K. D., Holub, B. J., Differential eicosapentaenoic acid elevations and altered cardiovascular disease risk factor responses after supplementation with docosahexaenoic acid in postmenopausal women receiving and not receiving hormone replacement therapy. Am. J. Clin. Nutr. 2004, 79, 765-773.
32. Folch, J., Lees, M., Sloane Stanley, G. H., A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 1957, 226, 497-509.
33. Morrison, W. R., Smith, L. M., Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride-methanol. J. Lipid Res. 1964, 5, 600-608.
34. Trygg, J., Wold, S., Orthogonal projections to latent structures (OPLS). J. Chemometrics 2002, 16, 119-128.
35. Quehenberger, O., Dennis, E. A., The human plasma lipidome. N. Engl. J. Med. 2011, 365, 1812-1823.
36. Quehenberger, O., Armando, A. M., Brown, A. H., Milne, S. B. et al., Lipidomics reveals a remarkable diversity of lipids in human plasma. J. Lipid Res. 2010, 51, 3299-3305.
37. Szymanska, E., van Dorsten, F. A., Troost, J., Paliukhovich, I. et al., A lipidomic analysis approach to evaluate the response to cholesterol-lowering food intake. Metabolomics 2012, 8, 894-906.
38. Psychogios, N., Hau, D. D., Peng, J., Guo, A. C. et al., The human serum metabolome. PLoS One 2011, 6, e16957.
39. Strassburg, K., Huijbrechts, A. M., Kortekaas, K. A., Lindeman, J. H. et al., Quantitative profiling of oxylipins through comprehensive LC-MS/MS analysis: application in cardiac surgery. Anal. Bioanal. Chem. 2012, 404, 1413-1426.
40. Giordano, R. M., Newman, J. W., Pedersen, T. L., Ramos, M. I. et al., Effects of dynamic exercise on plasma arachidonic acid epoxides and diols in human volunteers. Int. J. Sport Nutr. Exerc. Metab. 2011, 21, 471-479.
41. Yu, Z., Kastenmuller, G., He, Y., Belcredi, P. et al., Differences between human plasma and serum metabolite profiles. PLoS One 2011, 6, e21230.
42. Denery, J. R., Nunes, A. A., Dickerson, T. J., Characterization of differences between blood sample matrices in untargeted metabolomics. Anal. Chem. 2011, 83, 1040-1047.
43. Zivkovic, A. M., Yang, J., Georgi, K., Hegedus, C. et al., Serum oxylipin profiles in IgA nephropathy patients reflect kidney functional alterations. Metabolomics 2012, 8, 1102-1113.
44. Goodfriend, T. L., Pedersen, T. L., Grekin, R. J., Hammock, B. D. et al., Heparin, lipoproteins, and oxygenated fatty acids in blood: a cautionary note. Prostaglandins Leukot. Essent. Fatty Acids 2007, 77, 363-366.
45. Mas, E., Croft, K. D., Zahra, P., Barden, A. et al., Resolvins D1, D2, and other mediators of self-limited resolution of inflammation in human blood following n-3 fatty acid supplementation. Clin. Chem. 2012, 58, 1476-1484.
46. Sadilkova, L., Paluch, Z., Mottlova, J., Bednar, F. et al., The effect of selected pre-analytical phase variables on plasma thromboxane A(2) measurements in humans. Int. J. Lab. Hematol. 2013, 35, 92-100.
47. Warner, T. D., Nylander, S., Whatling, C., Anti-platelet therapy: cyclo-oxygenase inhibition and the use of aspirin with particular regard to dual anti-platelet therapy. Br. J. Clin. Pharmacol. 2011, 72, 619-633.
48. Weber, C., Beetens, J. R., Van de Wiele, R., Holler, M., De Clerck, F., Production of thromboxane and prostaglandins in human blood in the presence of thromboxane synthase inhibitors: a comparison of RIA and GC/MS determinations. Blood Coagul. Fibrinolysis 1991, 2, 7-15.
49. Gomolka, B., Siegert, E., Blossey, K., Schunck, W. H. et al., Analysis of omega-3 and omega-6 fatty acid-derived lipid metabolite formation in human and mouse blood samples. Prostaglandins Other Lipid Mediat. 2011, 94, 81-87.
50. Hamberg, M., Samuelsson, B., Prostaglandin endoperoxides. Novel transformations of arachidonic acid in human platelets. Proc. Natl. Acad. Sci. USA 1974, 71, 3400-3404.
51. Arm, J. P., Horton, C. E., Spur, B. W., Mencia-Huerta, J. M. et al., The effects of dietary supplementation with fish oil lipids on the airways response to inhaled allergen in bronchial asthma. Am. Rev. Respir. Dis. 1989, 139, 1395-1400.
52. McKeever, T. M., Britton, J., Diet and asthma. Am. J. Respir. Crit. Care Med. 2004, 170, 725-729.
53. Nagakura, T., Matsuda, S., Shichijyo, K., Sugimoto, H. et al., Dietary supplementation with fish oil rich in omega-3 polyunsaturated fatty acids in children with bronchial asthma. Eur. Respir. J. 2000, 16, 861-865.
54. Fogarty, A., Britton, J., The role of diet in the aetiology of asthma. Clin. Exp. Allergy 2000, 30, 615-627.
55. Broadfield, E. C., McKeever, T. M., Whitehurst, A., Lewis, S. A. et al., A case-control study of dietary and erythrocyte membrane fatty acids in asthma. Clin. Exp. Allergy 2004, 34, 1232-1236.
56. McKeever, T. M., Lewis, S. A., Cassano, P. A., Ocke, M. et al., The relation between dietary intake of individual fatty acids, FEV1 and respiratory disease in Dutch adults. Thorax 2008, 63, 208-214.